The Aids vaccine trials currently in progress in Kenya are for the first time going to be expanded to Rwanda where a new site has been located.
The move to bring Rwanda on board is seen by many researchers as an attempt by the scientists involved in the study and their financier to accelerate the vaccine trial process.
After spirited attempts to get low-priced anti-Aids drugs, many patients in Kenya may have started to reap the fruits of their struggle.
Our recent investigations indicate that prices have plummeted and a one-month triple therapy can now be bought at Sh 3,000 [about $40] compared to about Sh 50,000 [about $640] two years ago.
When James and his wife walked into one of the Voluntary Counseling and Testing centres to know their HIV status, they were just going to confirm what they have believed for so many years: they were HIV negative.